ID: ALA4538396

Max Phase: Preclinical

Molecular Formula: C34H37F3N6O13

Molecular Weight: 680.67

Molecule Type: Unknown

Representations

Canonical SMILES:  NC[C@H]1O[C@@H](O[C@@H](c2cn(CCCOc3ccc(C(=O)c4ccccc4)cc3)nn2)[C@H]2O[C@@H](n3ccc(=O)[nH]c3=O)[C@H](O)[C@@H]2O)[C@H](O)[C@@H]1O.O=C(O)C(F)(F)F

Standard InChI:  InChI=1S/C32H36N6O11.C2HF3O2/c33-15-21-24(41)27(44)31(47-21)49-28(29-25(42)26(43)30(48-29)38-13-11-22(39)34-32(38)45)20-16-37(36-35-20)12-4-14-46-19-9-7-18(8-10-19)23(40)17-5-2-1-3-6-17;3-2(4,5)1(6)7/h1-3,5-11,13,16,21,24-31,41-44H,4,12,14-15,33H2,(H,34,39,45);(H,6,7)/t21-,24-,25+,26-,27-,28+,29+,30-,31+;/m1./s1

Standard InChI Key:  AHHPTOVSCVPOQL-PLXRNELDSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 680.67

Molecular Weight (Monoisotopic): 680.2442

AlogP: -1.39

#Rotatable Bonds: 13

Polar Surface Area: 246.50

Molecular Species: BASE

HBA: 16

HBD: 6

#RO5 Violations: 3

HBA (Lipinski): 17

HBD (Lipinski): 7

#RO5 Violations (Lipinski): 3

CX Acidic pKa: 9.70

CX Basic pKa: 8.75

CX LogP: -0.72

CX LogD: -1.84

Aromatic Rings: 4

Heavy Atoms: 49

QED Weighted: 0.07

Np Likeness Score: 0.23

References

1. Patel B, Ryan P, Makwana V, Zunk M, Rudrawar S, Grant G..  (2019)  Caprazamycins: Promising lead structures acting on a novel antibacterial target MraY.,  171  [PMID:30933853] [10.1016/j.ejmech.2019.01.071]

Source

Source(1):

• Scientific Literature